Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine

Data de publicació:

Autors de IIS La Fe

Grups d'Investigació

Abstract

Background: Anticonvulsants are considered a second line option for bipolar disorder, it is known that the abrupt withdrawal is rarely related with demyelinated lesions of the splenium of the corpus callosum. Oxcarbazepine is used in bipolar disorder although it is not stated in the data sheet. Clinical case:: We presented a case of a 50 years old woman with bipolar disorder who is treated with lithium and oxcarbazepine, she presented a manic episode and a confusional syndrome after she stopped taking the medication. The magnetic resonance showed a restricted diffusion area at the splenium of the corpus callosum and bifrontal hygromas that disappear two weeks later. Conclusions: The results of this study suggest that for a patient presenting with a mild encephalopathy and reversible splenial lesion, one should consider whether it is related to withdrawal of oxcarbazepine.

Dades de la publicació

ISSN/ISSNe:
0165-0327, 1573-2517

JOURNAL OF AFFECTIVE DISORDERS  ELSEVIER SCIENCE BV

Tipus:
Editorial Material
Pàgines:
122-124
PubMed:
28027511
Factor d'Impacte:
2,053 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 3

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Oxcarbazepine; Manic episode; Bipolar disease; Encephalopathy

Compartir la publicació